Pharmala Biotech Holdings Inc
CNSX:MDMA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Pharmala Biotech Holdings Inc
CNSX:MDMA
|
CA |
Pharmala Biotech Holdings Inc
PharmAla Biotech Holdings Inc. is a Canada-based biotechnology company. The Company is focused on the research, development, and manufacturing of methylenedioxy phenethylamines (MDXX)-class molecules, including methylenedioxy methamphetamine (MDMA). The Company is involved in sourcing finished clinical-grade LaNeo MDMA Drug Products in North America. Its drug active pharmaceutical ingredients (API) are encapsulated under GMP conditions and are available to entities who have Controlled Substances licenses, Section 56 Ministerial Exemptions, or Clinical Trial numbers within Canada. It works with laboratories across Canada to develop processes for the supply of LaNeo MDMA and other MDXX substances.
PharmAla Biotech Holdings Inc. is a Canada-based biotechnology company. The Company is focused on the research, development, and manufacturing of methylenedioxy phenethylamines (MDXX)-class molecules, including methylenedioxy methamphetamine (MDMA). The Company is involved in sourcing finished clinical-grade LaNeo MDMA Drug Products in North America. Its drug active pharmaceutical ingredients (API) are encapsulated under GMP conditions and are available to entities who have Controlled Substances licenses, Section 56 Ministerial Exemptions, or Clinical Trial numbers within Canada. It works with laboratories across Canada to develop processes for the supply of LaNeo MDMA and other MDXX substances.
